Related Experiment Video
Updated: Jul 22, 2026

Construction of a Preclinical Multimodality Phantom Using Tissue-mimicking Materials for Quality Assurance in Tumor Size Measurement
Published on: July 29, 2013
A tri-modal tissue-equivalent anthropomorphic phantom for PET, CT and multi-parametric MRI radiomics
Francesca Gallivanone1, Daniela D'Ambrosio2, Irene Carne2
1Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan, Italy.
Researchers created a new, realistic 3D model of human tissue that can be scanned using PET, CT, and MRI. This tool helps scientists test how accurately and consistently medical imaging software can identify tumors, which is vital for improving cancer diagnosis and treatment planning.
Area of Science:
- Medical imaging physics within radiomics research
- Quantitative imaging biomarker development and validation
Background:
No prior work had resolved the need for realistic physical models to validate advanced image processing tools. Quantitative imaging biomarkers rely on precise measurements to ensure clinical reliability. Current methods often lack the required complexity to mimic human anatomy accurately. This gap motivated the creation of specialized tools for testing imaging systems. Prior research has shown that phantom measurements are necessary for assessing biomarker stability. However, few efforts were devoted to developing realistic anthropomorphic models for multi-modal imaging. That uncertainty drove the need for a versatile testing platform. Researchers require standardized objects to verify software performance across different hospital settings.
Purpose Of The Study:
The aim of this work was to develop a multi-modal image phantom suitable for PET, CT, and multiparametric MRI. Researchers sought to address the lack of realistic anthropomorphic models for validating quantitative imaging biomarkers. This study focuses on creating a tissue-equivalent mixture that maintains compatibility across different imaging modalities. The motivation stems from the need to define the accuracy and stability of biomarkers in clinical settings. By designing a versatile phantom, the authors intended to provide a tool for rigorous software testing. They aimed to simulate complex oncological lesions with irregular shapes and non-uniform contrast. This effort addresses the methodological requirements for both single-center and multi-center imaging studies. The team sought to establish a straightforward procedure for manufacturing these customizable testing objects.
Main Methods:
The review approach involved designing a gel-based mixture compatible with multiple scanning technologies. Investigators performed calibration assessments to determine the optimal composition for simulating diverse lesion contrasts. They fabricated synthetic lesions characterized by irregular geometries and varied signal intensities. These objects were integrated into a standard human-shaped frame to ensure anatomical relevance. The team evaluated the performance of the mixture by conducting simultaneous scans across different platforms. They addressed methodological challenges regarding biomarker stability through specific proof-of-concept experiments. The researchers documented a straightforward preparation protocol for the gel material. This systematic strategy allowed for the creation of a customizable tool for imaging validation.
Main Results:
The strongest finding indicates that the characterized gel mixture successfully mimics oncological lesion contrast in PET, CT, and MRI imaging simultaneously. The researchers demonstrated that the phantom provides a platform to address issues related to biomarker accuracy. They observed that the model supports the assessment of biomarker stability in various experimental setups. The study confirmed the reproducibility of measurements through the application of the developed phantom. The team successfully created synthetic lesions with irregular shapes and non-uniform contrast for testing purposes. These proofs-of-concept studies suggest that phantom measurements can be adapted for specific clinical situations. The results show that the manufacturing strategy is suitable for both mono-centric and multi-centric research studies. The authors report that the gel preparation procedure is straightforward for laboratory implementation.
Conclusions:
The authors suggest that their novel phantom provides a reliable platform for evaluating radiomic biomarker performance. This study demonstrates that the gel mixture effectively mimics oncological lesion contrast across three distinct imaging modalities. The researchers propose that these measurements can be tailored to address specific clinical scenarios. Their findings indicate that the developed strategy supports the assessment of biomarker accuracy and reproducibility. This work highlights the potential for using such models in both single-center and multi-center research environments. The team concludes that the straightforward preparation procedure facilitates the adoption of this tool in various settings. These results imply that phantom-based validation is a viable approach for standardizing complex imaging protocols. The authors emphasize that their approach enables the customization of testing procedures for diverse radiomic applications.
Frequently Asked Questions
The researchers propose that the gel mixture mimics oncological lesion contrast by simulating specific signal intensities. This allows for the simultaneous evaluation of PET, CT, and MRI imaging performance using a single, tissue-equivalent synthetic structure.
The team utilized a tissue-equivalent gel-based mixture as the core component. This material was specifically characterized to ensure compatibility and consistent contrast representation across the three different imaging modalities tested.
The authors state that calibration measurements are necessary to assess gel composition. This step ensures the synthetic lesions accurately reflect the physical properties of real oncological tissues during the scanning process.
The researchers employed synthetic lesions with irregular shapes and non-uniform image contrast. These features play a role in testing the sensitivity of radiomic software to complex, realistic tumor characteristics.
The study measured the accuracy, stability, and reproducibility of radiomic biomarkers. These metrics serve as indicators of how well imaging software performs under varied clinical conditions.
The authors propose that their manufacturing strategy allows for the customization of phantom measurements. This flexibility supports the development of protocols tailored to specific clinical situations or multi-centric research requirements.
Related Concept Videos
Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies III: Computed Tomography

